HRAS mutation mosaicism causing urothelial cancer and epidermal nevus

New England Journal of Medicine

Volumn 365, Issue 20, 2011, Pages 1940-1942

  Hafner, Christian ^a   Toll, Agusti ^b   Real, Francisco X ^c  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b HOSPITAL DEL MAR   (Spain)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FIBROBLAST GROWTH FACTOR RECEPTOR 3; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHATIDYLINOSITOL KINASE; PHOSPHATIDYLINOSITOL KINASE 3CA; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; BLADDER CARCINOMA; BLADDER MUSCLE; CANCER STAGING; CASE REPORT; COMPARATIVE GENOMIC HYBRIDIZATION; CONGENITAL EPIDERMAL NEVUS; CONGENITAL NEVUS; DISEASE FREE INTERVAL; GENE MUTATION; HUMAN; KIDNEY PELVIS CARCINOMA; LETTER; LEUKOCYTE; LUNG METASTASIS; LUNG PARENCHYMA; MALE; MOSAICISM; ONCOGENE H RAS; PRIORITY JOURNAL; SKIN HEMANGIOMA; TISSUE SPECIFICITY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; UROTHELIUM;

EID: 81455135721     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1109381     Document Type: Letter

References (5)

1. Lindhurst MJ, Sapp JC, Teer JK, et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med 2011;365:611-9.
2. Aoki Y, Niihori T, Kawame H, et al. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet 2005;37:1038-40. (Pubitemid 41486653)
3. Sol-Church K, Stabley DL, Demmer LA, et al. Male-to-male transmission of Costello syndrome: G12S HRAS germline mutation inherited from a father with somatic mosaicism. Am J Med Genet A 2009;149A:315-21.
4. Gripp KW, Stabley DL, Nicholson L, Hoffman JD, Sol-Church K. Somatic mosaicism for an HRAS mutation causes Costello syndrome. Am J Med Genet A 2006;140:2163-9. (Pubitemid 44522430)
5. Sugarman JL. Epidermal nevus syndromes. Semin Cutan Med Surg 2007;26:221-30. (Pubitemid 351458732)